MaxCyte (MXCT) Competitors $2.30 -0.01 (-0.43%) Closing price 04:00 PM EasternExtended Trading$2.24 -0.06 (-2.83%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MXCT vs. CTOS, NUTX, NEO, EEX, EVH, NXTT, YEXT, TIXT, RSKD, and IIIVShould you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include Custom Truck One Source (CTOS), Nutex Health (NUTX), NeoGenomics (NEO), Emerald (EEX), Evolent Health (EVH), Next Technology (NXTT), Yext (YEXT), TELUS Digital (TIXT), Riskified (RSKD), and i3 Verticals (IIIV). These companies are all part of the "business services" industry. MaxCyte vs. Custom Truck One Source Nutex Health NeoGenomics Emerald Evolent Health Next Technology Yext TELUS Digital Riskified i3 Verticals MaxCyte (NASDAQ:MXCT) and Custom Truck One Source (NYSE:CTOS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends, risk and community ranking. Which has higher valuation & earnings, MXCT or CTOS? Custom Truck One Source has higher revenue and earnings than MaxCyte. Custom Truck One Source is trading at a lower price-to-earnings ratio than MaxCyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaxCyte$37.68M6.52-$37.92M-$0.40-5.78Custom Truck One Source$1.81B0.59$50.71M-$0.13-36.50 Does the media prefer MXCT or CTOS? In the previous week, MaxCyte had 2 more articles in the media than Custom Truck One Source. MarketBeat recorded 4 mentions for MaxCyte and 2 mentions for Custom Truck One Source. MaxCyte's average media sentiment score of 0.96 beat Custom Truck One Source's score of 0.84 indicating that MaxCyte is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MaxCyte 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Custom Truck One Source 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is MXCT or CTOS more profitable? Custom Truck One Source has a net margin of -2.22% compared to MaxCyte's net margin of -78.36%. Custom Truck One Source's return on equity of -4.57% beat MaxCyte's return on equity.Company Net Margins Return on Equity Return on Assets MaxCyte-78.36% -16.00% -13.93% Custom Truck One Source -2.22%-4.57%-1.15% Does the MarketBeat Community prefer MXCT or CTOS? Custom Truck One Source received 8 more outperform votes than MaxCyte when rated by MarketBeat users. However, 70.59% of users gave MaxCyte an outperform vote while only 44.44% of users gave Custom Truck One Source an outperform vote. CompanyUnderperformOutperformMaxCyteOutperform Votes1270.59% Underperform Votes529.41% Custom Truck One SourceOutperform Votes2044.44% Underperform Votes2555.56% Do institutionals and insiders believe in MXCT or CTOS? 68.8% of MaxCyte shares are held by institutional investors. Comparatively, 90.1% of Custom Truck One Source shares are held by institutional investors. 3.3% of MaxCyte shares are held by company insiders. Comparatively, 4.5% of Custom Truck One Source shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more volatility & risk, MXCT or CTOS? MaxCyte has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Custom Truck One Source has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Do analysts recommend MXCT or CTOS? MaxCyte presently has a consensus target price of $7.50, suggesting a potential upside of 224.68%. Custom Truck One Source has a consensus target price of $5.25, suggesting a potential upside of 10.64%. Given MaxCyte's stronger consensus rating and higher probable upside, equities research analysts clearly believe MaxCyte is more favorable than Custom Truck One Source.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MaxCyte 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Custom Truck One Source 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 SummaryMaxCyte and Custom Truck One Source tied by winning 9 of the 18 factors compared between the two stocks. Get MaxCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MXCT vs. The Competition Export to ExcelMetricMaxCyteCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$245.82M$3.36B$5.55B$8.67BDividend YieldN/A2.24%5.27%4.19%P/E Ratio-6.79122.0627.2220.17Price / Sales6.52161.53423.71161.98Price / CashN/A34.5738.2534.64Price / Book1.042.597.134.72Net Income-$37.92M$118.81M$3.23B$247.80M7 Day Performance-3.35%4.86%3.78%2.75%1 Month Performance-2.53%11.26%13.34%9.70%1 Year Performance-50.64%-15.94%32.21%14.51% MaxCyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MXCTMaxCyte2.4566 of 5 stars$2.30-0.4%$7.50+226.1%-53.4%$244.76M$37.68M-6.7680Analyst UpgradeCTOSCustom Truck One Source1.013 of 5 stars$4.23-1.6%$5.25+24.1%+1.2%$954.50M$1.81B-26.441,800NUTXNutex Health2.8838 of 5 stars$167.96+0.1%$262.50+56.3%+1,827.1%$934.87M$624.28M-17.891,150Positive NewsNEONeoGenomics3.3781 of 5 stars$7.17-1.5%$13.83+92.9%-41.1%$922.74M$672.36M-11.562,100EEXEmerald1.4243 of 5 stars$4.63+1.1%$7.90+70.6%-17.7%$920.72M$413.10M-8.57600Positive NewsEVHEvolent Health1.8722 of 5 stars$7.57+1.5%$17.79+135.1%-62.1%$888.13M$2.40B-9.235,100NXTTNext Technology1.3056 of 5 stars$1.91flatN/A-60.3%$833.27M$1.80M0.008Positive NewsYEXTYext1.494 of 5 stars$6.68-0.5%$9.00+34.8%+71.5%$831.65M$420.96M-44.501,400TIXTTELUS Digital2.8113 of 5 stars$2.94+2.6%$4.07+38.6%-50.7%$809.03M$2.67B-8.3973,100RSKDRiskified2.0013 of 5 stars$5.01flat$6.03+20.4%-17.5%$807.66M$333.50M-25.05780IIIVi3 Verticals4.3481 of 5 stars$23.83-3.6%$29.57+24.1%+28.3%$791.56M$241.65M5.311,640Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Custom Truck One Source Alternatives Nutex Health Alternatives NeoGenomics Alternatives Emerald Alternatives Evolent Health Alternatives Next Technology Alternatives Yext Alternatives TELUS Digital Alternatives Riskified Alternatives i3 Verticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MXCT) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MXCT Stock Free MXCT Stock Alerts